| |
original article |
Date |
Title |
Authors All Authors |
| 1 |
[GO] |
2022―Sep―26 |
How COVID-19 stole our sense of smell |
Laura Howes |
| 2 |
[GO] |
2022―Sep―12 |
Comment: The challenge of sustainable development in the era of COVID-19 |
Matt Fisher, Chair, ACS Committee on Science |
| 3 |
[GO] |
2022―Sep―12 |
China approves the first inhalable COVID-19 vaccine |
Shi En Kim |
| 4 |
[GO] |
2022―Sep―05 |
Moderna sues Pfizer and BioNTech over COVID-19 vaccine |
Gina Vitale |
| 5 |
[GO] |
2022―Jul―25 |
Paper strip detects SARS-CoV-2 variants |
Mark Peplow, special to C&EN |
| 6 |
[GO] |
2022―Jul―18 |
How long the coronavirus survives in air depends on relative humidity |
Krystal Vasquez |
| 7 |
[GO] |
2022―Jun―06 |
Peptide from SARS-CoV-2 spike protein forms amyloids |
Celia Henry Arnaud |
| 8 |
[GO] |
2022―May―23 |
New insights into 1918 flu pandemic from samples in a Berlin museum |
Laura Howes |
| 9 |
[GO] |
2022―May―09 |
COVID-19 put hand sanitizer-and Purell lead formulator Kayla Ivey-in the spotlight |
Carmen Drahl, special to C&EN |
| 10 |
[GO] |
2022―Mar―28 |
The next generation of COVID-19 antivirals |
Jared Whitlock, special to C&EN |
| 11 |
[GO] |
2022―Mar―28 |
The petrochemical industry’s pandemic hangover |
Alexander H. Tullo |
| 12 |
[GO] |
2022―Feb―28 |
The easing of pandemic-related restrictions offers light at the end of the tunnel |
Bibiana Campos-Seijo |
| 13 |
[GO] |
2022―Jan―31 |
Pittcon 2022 is canceled because of COVID-19 |
Craig Bettenhausen |
| 14 |
[GO] |
2022―Jan―31 |
COVID-19 lockdowns prevented pollution-related deaths |
Laura Howes |
| 15 |
[GO] |
2022―Jan―24 |
How Pfizer scientists transformed an old drug lead into a COVID-19 antiviral |
Bethany Halford |
| 16 |
[GO] |
2022―Jan―24 |
Podcast: Jose-Luis Jimenez and Kimberly Prather on how public health history has influenced what we know about COVID-19 transmission, and lessons for science communication |
Jyllian Kemsley |
| 17 |
[GO] |
2022―Jan―24 |
Cleaning changed during the pandemic, and it may not change back |
Craig Bettenhausen |
| 18 |
[GO] |
2022―Jan―17 |
US chemical industry looks to put pandemic woes behind it in 2022 |
Alexander H. Tullo |
| 19 |
[GO] |
2021―Dec―17 |
Scientists learned from COVID-19 missteps in 2021 |
Sam Lemonick |
| 20 |
[GO] |
2021―Dec―17 |
4′-Fluorouridine fights respiratory viruses, including SARS-CoV-2, in animals |
Bethany Halford |
| 21 |
[GO] |
2021―Dec―17 |
Looking at my ACS presidential year through the eyes of a pandemic |
Luis A Echegoyen, ACS immediate past president |
| 22 |
[GO] |
2021―Dec―06 |
Sterling to develop low-cost COVID-19 therapy |
Rick Mullin |
| 23 |
[GO] |
2021―Dec―06 |
The world is leaning on pills to end the pandemic |
Bethany Halford |
| 24 |
[GO] |
2021―Nov―22 |
Pfizer to license COVID-19 antiviral |
Michael McCoy |
| 25 |
[GO] |
2021―Nov―08 |
Graphene transistor detects SARS-CoV-2 in less than a minute |
Mark Peplow, special to C&EN |
| 26 |
[GO] |
2021―Nov―01 |
Merck to let other firms make its COVID-19 pill |
Ryan Cross |
| 27 |
[GO] |
2021―Nov―01 |
How pregnancy affects COVID-19 vaccine effectiveness |
Laura Howes |
| 28 |
[GO] |
2021―Oct―25 |
Women submitted fewer papers during the start of COVID-19 |
Andrea Widener |
| 29 |
[GO] |
2021―Oct―25 |
A strong and stable IP system incentivizes tools to combat COVID-19 |
Carlyn Burton, chair, ACS Committee on Patents and... |
| 30 |
[GO] |
2021―Oct―25 |
Atea’s COVID-19 antiviral fails in Phase 2 trials |
Megha Satyanarayana |
| 31 |
[GO] |
2021―Oct―18 |
CureVac pulls its COVID-19 vaccine from EMA approval process |
Megha Satyanarayana |
| 32 |
[GO] |
2021―Oct―11 |
Molnupiravir reduces risk of hospitalization and death in patients with mild to moderate COVID-19 |
Bethany Halford |
| 33 |
[GO] |
2021―Oct―11 |
Coping with COVID-19 uncertainty-again |
Jen Heemstra, special to C&EN |
| 34 |
[GO] |
2021―Oct―11 |
EPA approves COVID-19-killing paint from Corning and PPG |
Craig Bettenhausen |
| 35 |
[GO] |
2021―Oct―04 |
In preclinical tests, Merck’s COVID-19 antiviral seems to work against variants |
Megha Satyanarayana |
| 36 |
[GO] |
2021―Oct―04 |
Sanofi ditches mRNA vaccine for COVID-19 |
Ryan Cross |
| 37 |
[GO] |
2021―Sep―27 |
Weighing wastewater’s worth as a COVID-19 monitoring tool |
Celia Henry Arnaud |
| 38 |
[GO] |
2021―Sep―27 |
Can breath tests sniff out COVID-19? |
Carrie Arnold, special to C&EN |
| 39 |
[GO] |
2021―Sep―27 |
How the the drug services industry found itself prepared for a pandemic |
Rick Mullin |
| 40 |
[GO] |
2021―Sep―13 |
Two COVID-19 antiviral pills advance to late-stage trials |
Megha Satyanarayana |
| 41 |
[GO] |
2021―Sep―13 |
Gates Foundation and Exscientia to develop pandemic antivirals |
Megha Satyanarayana |
| 42 |
[GO] |
2021―Sep―07 |
How to interpret new studies on coronavirus variants |
Laura Howes |
| 43 |
[GO] |
2021―Aug―30 |
FDA approves the Pfizer-BioNTech COVID-19 vaccine |
Megha Satyanarayana |
| 44 |
[GO] |
2021―Aug―30 |
Quat disinfectants are helping during the pandemic. But could they contribute to antibiotic resistance? |
XiaoZhi Lim, special to C&EN |
| 45 |
[GO] |
2021―Aug―09 |
Francis Collins on the urgent need for COVID-19 antivirals |
Lisa M. Jarvis |
| 46 |
[GO] |
2021―Aug―02 |
Air pollution disparities persisted during COVID-19 lockdowns |
Katherine Bourzac |
| 47 |
[GO] |
2021―Aug―02 |
Computational scientists look for lessons learned from the COVID-19 pandemic |
Sam Lemonick |
| 48 |
[GO] |
2021―Jul―26 |
Single-use plastics have boomed during COVID-19. Joana Correia Prata wants to reverse the trend |
Carmen Drahl, special to C&EN |
| 49 |
[GO] |
2021―Jul―19 |
Global climate change talks resume after delay from COVID-19 |
Cheryl Hogue |
| 50 |
[GO] |
2021―Jul―19 |
COVID-19 vaccine plant planned for Senegal |
Megha Satyanarayana |
| 51 |
[GO] |
2021―Jul―12 |
Reemerging after COVID-19 |
Brought to you by ACS Careers |
| 52 |
[GO] |
2021―Jul―12 |
The antivirals that weren’t: Drug repurposing for COVID-19 produced misleading results |
Leigh Krietsch Boerner |
| 53 |
[GO] |
2021―Jun―28 |
Coronavirus epidemics are part of human history |
Laura Howes |
| 54 |
[GO] |
2021―Jun―21 |
Novavax vaccine shows strong protection against COVID-19 |
Ryan Cross |
| 55 |
[GO] |
2021―Jun―21 |
COVID-19 test used in UK mass-screening program receives stinging rebuke from the FDA |
Mark Peplow, special to C&EN |
| 56 |
[GO] |
2021―Jun―14 |
The global mass of SARS-CoV-2 |
Laura Howes |
| 57 |
[GO] |
2021―Jun―14 |
Pandemic experiments prove CO₂ monitoring networks provide real-time emission information |
Katherine Bourzac |
| 58 |
[GO] |
2021―Jun―07 |
Vir and GSK monoclonal antibody authorized for emergency use in COVID-19 |
Ryan Cross |
| 59 |
[GO] |
2021―Jun―07 |
Intranasal vaccines aim to stop COVID-19 where it starts |
Ryan Cross |
| 60 |
[GO] |
2021―Jun―01 |
Over-the-counter COVID-19 tests make big promises. Do they deliver? |
Megha Satyanarayana |
| 61 |
[GO] |
2021―Jun―01 |
CEPI bets big on SK Bioscience COVID-19 vaccine |
Ryan Cross |
| 62 |
[GO] |
2021―Jun―01 |
COVID-19: What you need to know about SARS-CoV-2 variants |
Laura Howes |
| 63 |
[GO] |
2021―May―24 |
To conquer COVID-19, create the perfect pill |
Bethany Halford |
| 64 |
[GO] |
2021―May―24 |
Medicago, GSK announce positive data for tobacco-grown COVID-19 vaccine |
Megha Satyanarayana |
| 65 |
[GO] |
2021―May―17 |
12-to-15-year-olds can now get Pfizer COVID-19 vaccine |
Ryan Cross |
| 66 |
[GO] |
2021―May―10 |
mRNA COVID-19 vaccines by the numbers |
|
| 67 |
[GO] |
2021―May―03 |
Sanofi agrees to help manufacture Moderna’s COVID-19 vaccine |
Megha Satyanarayana |
| 68 |
[GO] |
2021―Apr―19 |
Regeneron antibody cocktail could be used to prevent COVID-19 |
Megha Satyanarayana |
| 69 |
[GO] |
2021―Apr―12 |
X-ray screening finds two drugs that could help treat COVID-19 |
Laura Howes |
| 70 |
[GO] |
2021―Apr―12 |
How ACS is emerging from COVID-19 restrictions and planing for the future |
Paul W. Jagodzinski, chair, ACS Board of Directors |
| 71 |
[GO] |
2021―Apr―12 |
UT Austin and Mount Sinai partner to create low-cost COVID-19 vaccine |
Ryan Cross |
| 72 |
[GO] |
2021―Apr―12 |
AstraZeneca’s COVID-19 vaccine-related woes grow |
Megha Satyanarayana |
| 73 |
[GO] |
2021―Apr―12 |
Pfizer unveils its oral SARS-CoV-2 inhibitor |
Bethany Halford |
| 74 |
[GO] |
2021―Apr―05 |
Coffee capsules put to use for coronavirus tests |
Laura Howes |
| 75 |
[GO] |
2021―Apr―05 |
Structural biologists clean up SARS-CoV-2 protein structures |
Laura Howes |
| 76 |
[GO] |
2021―Mar―29 |
Woes mount for AstraZeneca’s COVID-19 vaccine |
Ryan Cross |
| 77 |
[GO] |
2021―Mar―22 |
Leprosy drug fights COVID-19 in hamsters |
Bethany Halford |
| 78 |
[GO] |
2021―Mar―22 |
Women scientists are more affected by the COVID-19 pandemic than men |
Andrea Widener |
| 79 |
[GO] |
2021―Mar―22 |
COVID-19 pandemic: 1 year later |
Bibiana Campos-Seijo |
| 80 |
[GO] |
2021―Mar―22 |
Tobacco-grown COVID-19 vaccine moves ahead |
Lisa M. Jarvis |
| 81 |
[GO] |
2021―Mar―22 |
COVID-19 vaccine trials for kids ramp up |
Ryan Cross |
| 82 |
[GO] |
2021―Mar―22 |
Petrochemicals to slump post pandemic |
Alexander H. Tullo |
| 83 |
[GO] |
2021―Mar―22 |
Undergrads hit hard by pandemic navigate disruptions |
Michele Solis, special to C&EN |
| 84 |
[GO] |
2021―Mar―15 |
FDA authorizes COVID-19 diagnostic that uses immune cells |
Megha Satyanarayana |
| 85 |
[GO] |
2021―Mar―15 |
Which air purification technologies can tackle COVID-19? |
Mark Peplow, special to C&EN |
| 86 |
[GO] |
2021―Mar―15 |
CEPI has $3.5 billion plan to prevent pandemics |
Ryan Cross |
| 87 |
[GO] |
2021―Mar―08 |
Without these lipid shells, there would be no mRNA vaccines for COVID-19 |
Ryan Cross |
| 88 |
[GO] |
2021―Mar―08 |
J&J shot is third COVID-19 vaccine authorized in US |
Ryan Cross |
| 89 |
[GO] |
2021―Mar―08 |
The pandemic cut emissions, but did it help climate? |
Katherine Bourzac |
| 90 |
[GO] |
2021―Mar―01 |
US FDA outlines how to adapt COVID-19 vaccines, drugs and diagnostics to virus variants |
Asher Mullard, special to C&EN |
| 91 |
[GO] |
2021―Feb―22 |
Lipids, the unsung COVID-19 vaccine component, get investment |
Michael McCoy |
| 92 |
[GO] |
2021―Feb―22 |
Gene circuits repurpose glucose meters to detect pathogens, including SARS-CoV-2 |
Celia Henry Arnaud |
| 93 |
[GO] |
2021―Feb―22 |
Podcast: Nobel laureates Frances Arnold and Jennifer Doudna on prizes, pandemics, and Jimmy Page |
Lisa M. Jarvis |
| 94 |
[GO] |
2021―Feb―08 |
Novartis and Sanofi to help make Pfizer-BioNTech COVID-19 vaccine |
Rick Mullin |
| 95 |
[GO] |
2021―Feb―01 |
Lilly’s COVID-19 antibody treatment reduces death, hospitalizations |
Megha Satyanarayana |
| 96 |
[GO] |
2021―Feb―01 |
Plitidepsin, a molecule from sea squirts, could be a COVID-19 antiviral |
Bethany Halford |
| 97 |
[GO] |
2021―Feb―01 |
What US chemists made before the COVID-19 pandemic, according to the 2020 ACS salary survey |
Andrea Widener |
| 98 |
[GO] |
2021―Feb―01 |
COVID-19 vaccines tested against new virus variants |
Ryan Cross |
| 99 |
[GO] |
2021―Feb―01 |
How the pandemic changed the industrial chemistry workplace |
Chemjobber, special to C&EN |
| 100 |
[GO] |
2021―Jan―25 |
Remembering the chemists we lost to COVID-19 |
Linda Wang |
| 101 |
[GO] |
2021―Jan―25 |
C&EN reflects on what science has learned from COVID-19 |
Bibiana Campos-Seijo |
| 102 |
[GO] |
2021―Jan―25 |
Surface swabbing helps researchers get a handle on COVID-19 cases |
Mark Peplow, special to C&EN |
| 103 |
[GO] |
2021―Jan―25 |
How COVID-19 has changed the culture of science |
Bethany Halford |
| 104 |
[GO] |
2021―Jan―25 |
A year in the COVID-19 pandemic |
|
| 105 |
[GO] |
2021―Jan―25 |
COVID-19: Science’s greatest test |
Lisa M. Jarvis |
| 106 |
[GO] |
2021―Jan―25 |
8 tools that helped us tackle the coronavirus |
Ryan Cross |
| 107 |
[GO] |
2021―Jan―25 |
Will public trust in science survive the pandemic? |
Ryan Cross |
| 108 |
[GO] |
2021―Jan―11 |
Petrochemicals get past the pandemic, but the building spree may slow |
Alexander H. Tullo |
| 109 |
[GO] |
2021―Jan―11 |
Pandemic stress: The toll it’s taking on students |
Wynne Parry, special to C&EN |
| 110 |
[GO] |
2021―Jan―04 |
Aerosol expert Jose-Luis Jimenez is sounding the alarm about airborne transmission of COVID-19 |
Carmen Drahl, special to C&EN |
| 111 |
[GO] |
2021―Jan―04 |
US funds potential COVID-19 therapy from Merck |
Ryan Cross |
| 112 |
[GO] |
2021―Jan―04 |
Moderna’s COVID-19 vaccine to roll out across the US |
Ryan Cross |
| 113 |
[GO] |
2020―Dec―21 |
Can the UK’s ambitious Operation Moonshot screening program for COVID-19 achieve liftoff? |
Mark Peplow, special to C&EN |
| 114 |
[GO] |
2020―Dec―21 |
Pfizer COVID-19 vaccine rolls out across the US |
Ryan Cross |
| 115 |
[GO] |
2020―Dec―21 |
Coronavirus research dominated 2020 |
Laura Howes |
| 116 |
[GO] |
2020―Dec―07 |
Ginkgo to expand COVID-19 response with $1.1 billion US government loan |
Melody M. Bomgardner |
| 117 |
[GO] |
2020―Dec―07 |
The UK RECOVERY trial: An ambitious test of COVID-19 treatments |
Megha Satyanarayana |
| 118 |
[GO] |
2020―Dec―07 |
Biotech start-ups launched in spite of the pandemic |
Ryan Cross |
| 119 |
[GO] |
2020―Nov―30 |
Wacker to produce COVID-19 vaccine for CureVac |
Alex Scott |
| 120 |
[GO] |
2020―Nov―30 |
Case study 1: A paint that kills COVID-19 with Cu+1 |
Craig Bettenhausen |
| 121 |
[GO] |
2020―Nov―23 |
Combined COVID-19 and flu tests could help overwhelmed hospitals |
Megha Satyanarayana |
| 122 |
[GO] |
2020―Nov―23 |
Monitoring COVID-19 in sewage |
Celia Henry Arnaud |
| 123 |
[GO] |
2020―Nov―23 |
Nanofibers put a new spin on COVID-19 masks |
Fernando Gomollón-Bel, special to C&EN |
| 124 |
[GO] |
2020―Nov―23 |
FDA grants EUA to at-home COVID-19 test |
Megha Satyanarayana |
| 125 |
[GO] |
2020―Nov―23 |
Moderna says COVID-19 vaccine is 94.5% effective in preliminary analysis |
Ryan Cross |
| 126 |
[GO] |
2020―Nov―23 |
Short CO₂ supply may complicate COVID-19 vaccine rollout |
Craig Bettenhausen |
| 127 |
[GO] |
2020―Nov―23 |
Structure of SARS-CoV-2 envelope protein solved by NMR |
Laura Howes |
| 128 |
[GO] |
2020―Nov―23 |
Amid pandemic, chemical firms invest in R&D |
Michael McCoy |
| 129 |
[GO] |
2020―Nov―16 |
Lilly earns first authorization for novel antibody therapy for COVID-19 |
Ryan Cross |
| 130 |
[GO] |
2020―Nov―16 |
Pfizer and BioNTech say their COVID-19 vaccine is successful in late-stage trial |
Ryan Cross |
| 131 |
[GO] |
2020―Nov―09 |
Roche partners with Atea on COVID-19 antiviral |
Ryan Cross |
| 132 |
[GO] |
2020―Nov―02 |
How one university built a COVID-19 screening system |
Mark Peplow, special to C&EN |
| 133 |
[GO] |
2020―Nov―02 |
Novartis gets access to COVID-19 therapies |
Michael McCoy |
| 134 |
[GO] |
2020―Oct―26 |
Tests alone won’t stop COVID-19 from spreading |
Megha Satyanarayana |
| 135 |
[GO] |
2020―Oct―26 |
COVID-19 pandemic causes 6-month plunge in CO₂ emissions |
Katherine Bourzac |
| 136 |
[GO] |
2020―Oct―26 |
New opportunities amid the challenges of the pandemic |
Lee H. Latimer, ACS director-at-large |
| 137 |
[GO] |
2020―Oct―19 |
AstraZeneca gets $486 million to test and manufacture COVID-19 antibody therapy |
Ryan Cross |
| 138 |
[GO] |
2020―Oct―19 |
Characterizing SARS-CoV-2 antibodies |
Laura Howes |
| 139 |
[GO] |
2020―Oct―19 |
How ACS student chapters are adapting to the pandemic |
Linda Wang |
| 140 |
[GO] |
2020―Oct―12 |
Lilly applies for emergency use authorization for COVID-19 antibody treatment |
Megha Satyanarayana |
| 141 |
[GO] |
2020―Oct―12 |
Small molecule takes aim at the RNA of SARS-CoV-2 |
Carolyn Wilke, special to C&EN |
| 142 |
[GO] |
2020―Oct―05 |
Regeneron offers early look at COVID-19 antibody cocktail data |
Lisa M. Jarvis |
| 143 |
[GO] |
2020―Oct―05 |
Biochemistry to boost garlic breath and canine COVID-19 detection |
Laura Howes |
| 144 |
[GO] |
2020―Oct―05 |
Can you get COVID-19 in the bathroom? |
Laura Howes |
| 145 |
[GO] |
2020―Oct―05 |
The tiny tweak behind COVID-19 vaccines |
Ryan Cross |
| 146 |
[GO] |
2020―Sep―28 |
Pfizer tests COVID-19 antiviral heads to clinical trials |
Bethany Halford |
| 147 |
[GO] |
2020―Sep―28 |
COVID-19 lockdowns had strange effects on air pollution across the globe |
Katherine Bourzac |
| 148 |
[GO] |
2020―Sep―28 |
Impact of COVID-19 on ACS finances |
William J. Greenlee |
| 149 |
[GO] |
2020―Sep―28 |
Vials vital for COVID-19 vaccine |
Cheryl Hogue |
| 150 |
[GO] |
2020―Sep―28 |
Coronavirus concerns dampen chemists’ economic outlook |
Andrea Widener |
| 151 |
[GO] |
2020―Sep―28 |
Glycans on SARS-CoV-2 may help the virus infect cells |
Alla Katsnelson, special to C&EN |
